Matthew Stanton
Stock Analyst at Jefferies
(n/a)
# 3,098
Out of 4,479 analysts
4
Total ratings
n/a
Success rate
-49.68%
Average return
Main Sectors:
4 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Assumes: Buy | $17 → $21 | $6.39 | +228.64% | 1 | Apr 4, 2024 | |
| LAB Standard BioTools | Initiates: Buy | $3.25 | $1.73 | +87.86% | 1 | Apr 4, 2024 | |
| BLFS BioLife Solutions | Initiates: Buy | $22 | $20.79 | +5.82% | 1 | Apr 4, 2024 | |
| AZTA Azenta | Initiates: Hold | $64 | $51.04 | +25.39% | 1 | Apr 4, 2024 |
Cryoport
Apr 4, 2024
Assumes: Buy
Price Target: $17 → $21
Current: $6.39
Upside: +228.64%
Standard BioTools
Apr 4, 2024
Initiates: Buy
Price Target: $3.25
Current: $1.73
Upside: +87.86%
BioLife Solutions
Apr 4, 2024
Initiates: Buy
Price Target: $22
Current: $20.79
Upside: +5.82%
Azenta
Apr 4, 2024
Initiates: Hold
Price Target: $64
Current: $51.04
Upside: +25.39%